Emily Jenson
Medical · Scottsdale, AZNPI 1932641594
Payments from drug & device makers
Across 170 payments — averaging $23.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$497
- Sanofi$278
- Novartis$264
- Regeneron Healthcare Solutions, Inc.$261
- Sun Pharmaceutical Industries Inc.$228
- plus $1K from 15 others
What the payments were for
- Food & beverage$3,60891%
- Education$3639%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 50 | $1,105 |
| Johnson & Johnson | 12 | $497 |
| Sanofi | 11 | $278 |
| Novartis | 13 | $264 |
| Regeneron Healthcare Solutions, Inc. | 9 | $261 |
| Sun Pharmaceutical Industries Inc. | 9 | $228 |
| Amgen | 10 | $221 |
| Pfizer | 12 | $211 |
| Dermavant Sciences, Inc. | 8 | $149 |
| E.r. Squibb & Sons, L.L.C. | 6 | $136 |
| Galderma Laboratories, L.p. | 4 | $101 |
| UCB, Inc. | 5 | $89 |
| Lilly USA, LLC | 5 | $80 |
| Inari Medical, Inc. | 1 | $79 |
| Incyte Corporation | 4 | $79 |
| Almirall LLC | 4 | $66 |
| Arcutis Biotherapeutics, Inc. | 2 | $46 |
| Organon | 2 | $42 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $15 |
| Oxford Immunotec USA Inc | 1 | $14 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $11 |
How this compares
$3,971 in reported general payments places this provider in the 80th percentile of 748 medical providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 247 | $7,650 |
| Fluorouracil | 83 | $4,902 |
| Calcipotriene | 24 | $4,148 |
| Triamcinolone Acetonide | 296 | $3,537 |
| Doxycycline Hyclate | 99 | $2,948 |
| Metronidazole | 57 | $2,767 |
| Clindamycin Phosphate | 54 | $1,737 |
| Hydrocortisone | 326 | $1,644 |
| Tacrolimus | 13 | $1,308 |
| Ciclopirox | 41 | $1,000 |
| Clotrimazole | 49 | $731 |
| Desonide | 21 | $731 |
| ValacyclovirValacyclovir Hcl | 52 | $723 |
| Cephalexin | 48 | $649 |
| Betamethasone Dipropionate | 14 | $607 |
Paid to pharmacies, not to this prescriber.
Other medical in Scottsdale
- Robert CasquejoScottsdale$474K
- Darren WestScottsdale$206K
- Jamie WystrachScottsdale$79K
- Kendall JensonScottsdale$39K
- Ann Marie ChavezScottsdale$23K
- Emma ReeveScottsdale$15K
- Fiona BluntScottsdale$12K
- Francine MartynScottsdale$10K
- Victoria CarpenterScottsdale$9K
- Andrew HicksPeoria$460K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.